Overview Methods of T Cell Depletion Trial (MoTD) Status: Recruiting Trial end date: 2025-06-01 Target enrollment: Participant gender: Summary A multi-centre phase II trial of GvHD prophylaxis following unrelated donor stem cell transplantation comparing Thymoglobulin vs. Calcineurin inhibitor or Sirolimus-based post-transplant cyclophosphamide. Phase: Phase 2 Details Lead Sponsor: University of BirminghamTreatments: CyclophosphamideCyclosporineCyclosporinsMycophenolic AcidSirolimusThymoglobulin